Press Releases
Jardiance® Demonstrated Cardiovascular (CV) Risk Reduction In People With...
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial investigating cardiovascular...
Press Releases
Lilly’s Humalog® 200 Units/ML KwikPen® Now Available In U.S....
First and only concentrated mealtime insulin analog may help people with diabetes fit their treatment into their daily lives Humalog® 200 units/mL KwikPen® (insulin lispro...
Press Releases
U.S. Food and Drug Administration Extends Action Date for...
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has extended the action date for the supplemental Biologics License Application...
Press Releases
Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O...
Company enters into a collaboration agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute as part...
Press Releases
Bristol-Myers Squibb and The Leukemia & Lymphoma Society Announce...
"With the life expectancy of more CML patients increasing, the need for routine PCR testing is very important to ensure optimal treatment results" Bristol-Myers Squibb...
Press Releases
Pall Purchases Exclusive License to Cutting-Edge Acoustic Wave Separation...
Pall Corporation, a global leader in filtration, separation and purification, announced the signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology...
Press Releases
Venturing into chemicals in France
Invest in Grenoble-Isère and Rhône Valley - ACHEMA 2015 Hall 9.2, stand D41 Adisseo, Hexcel, Vencorex, Arkema… major international chemical industry stakeholders are investing more...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.